参考文献/References:
[1] 倪语星,尚 红.临床微生物学检验[M].5版.北京:人民卫生出版社,2012:121-123.
Ni YX,Shang H.Clinical microbiology test[M].5th Ed.Beijing:People's Publishing House,2012:121-123.
[2] 杨银梅,陈 斌,彭颖仪,等.VITEK 2 Compact全自动微生物分析系统检测亚胺培南耐药鲍曼不动杆菌对阿米卡星的准确性评估[J].检验医学,2016,31(10):907-910.
Yang YM,Chen B,Peng YY,et al.Acuuracy of VITEK-2 compact for the determination of imipenemresistant Acinetobacter baumannii to Amikacin[J].Laboratory Medicine,2016,31(10):907-910.
[3] Clinical and Laboratory Standards Institute.Performance stardards for antimicrobial susceptibility testing[S].Wayne:PA,CLSI M100-S26:2016.
[4] Vardakas KZ,Matthaiou DK,Falagas ME,et al.Cha-racteristics,risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections inthe intensive care unit[J].J Infect,2015,70(6):592-599.
[5] 张河林,赵飞俊,何凤屏,等.2 527株临床分离病原菌的耐药性分析[J].现代检验医学杂志,2015,30(2):87-90.
Zhang HL,Zhao FJ,He FP,et al.Drug resistance spectrum analysis of 2 527 clinical isolates of bacteria[J].J Mod Lab Med,2015,30(2):87-90.
[6] Khatri A,Naeger Murphy N,Wiest P,et al.Community-acquired pyelonephritis in pregnancy caused by KPC-producing Klebsiela pneumoniae[J].Antimicrob Agents Chemother,2015,59(8):4375-4378.
[7] 程 莉,谭婷婷,魏红霞,等.临床分离的耐碳青霉烯肺炎克雷伯菌的耐药机制研究[J].现代检验医学杂志,2017,32(3):112-114.
Cheng L,Tan TT,Wei HX,et al.Resistance mechanisms of clinical isolated carbapenem-resistant Klebsiella pneumoniae[J].J Mod Lab Med,2017,32(3):112-114.
[8] 杨 朵,胡智颖,辛续丽.碳青霉烯类耐药肺炎克雷伯菌中KPC基因分布[J].中国感染与化疗杂志,2016,16(4):465-467.
Yang D,Hu ZY,Xin XL.Prevalence of KPC gene in carbapenem-resistant Klebsiella pneumoniae isolates[J].Chin J Infect Chemother,2016,16(4):465-467.
[9] 黄晓春,陈 岩,李 园,等.VITEK 2C检测鲍曼不动杆菌对阿米卡星体外敏感性的性能评价[J].检验医学,2013,28(8):666-670.
Huang XC,Chen Y,Li Y,et al.Evaluation on the performance of VITEK 2C for the susceptibility of Acinetobacter baumannii to Amikacin[J].Laboratory Medicine,2013,28(8):666-670.
[10] Bremmer DN,Clancy CJ,Press EG,et al.KPC-producing Klebsiella pneumoniae strains that harbor AAC(6')-Ib exhibit intermediate resistanceto amikacin[J].Antimicrob Agents Chemother,2014,58(12):7597-7600.
[11] Chiem K,Fuentes BA,Lin DL,et al.Inhibition of aminoglycoside 6'-N-acetyltransferase type Ib-mediated amikacin resistance in Klebsiella pneumoniae by zinc and copper pyrithione[J].Antimicrob Agents Chemother,2015,59(9):5851-5853.
[12] Haldorsen BC,Simonsen GS,Sundsfjord A,et al.Increased prevalence ofaminoglycoside resistance in clinical isolates of Escherichia coli and Klebsiella spp.In Norway is associated with the acquisition of AAC(3)-II and AAC(6')-Ib[J].Diagnostic Microbiology and Infectious Disease,2014,78(1):66-69.
收稿日期:2017-11-02
修回日期:2017-11-24
相似文献/References:
[1]周朝琼,邓 劲,刘 翔,等.重症监护室患者耐碳青霉烯类肺炎克雷伯菌流行病学研究及同源性分析[J].现代检验医学杂志,2019,34(04):71.[doi:10.3969/j.issn.1671-7414.2019.04.017]
ZHOU Chao-qiong,DENG Jin,LIU Xiang,et al.Epidemiological Study and Homology Analysis of Carbapenem-Resistant
Klebsiella Pneumoniae in Intensive Care Unit Patients[J].Journal of Modern Laboratory Medicine,2019,34(01):71.[doi:10.3969/j.issn.1671-7414.2019.04.017]
[2]周淑燕,柳丽娟,卓传尚,等.梅里埃MALDI-TOF-MS 系统与VITEK 2 Compact 全自动微生物鉴定仪对临床常见病原菌鉴定的一致性分析[J].现代检验医学杂志,2020,35(02):92.[doi:10.3969/j.issn.1671-7414.2020.02.026]
ZHOU Shu-yan,LIU Li-juan,ZHUO Chuan-shang,et al.Consistency Analyzer for Identification of Common Clinical PathogenicBacteria by the Merrier MALDI-TOF-MS System and VITEK 2 Compact[J].Journal of Modern Laboratory Medicine,2020,35(01):92.[doi:10.3969/j.issn.1671-7414.2020.02.026]